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Abstract 
A n autoreactive T cell clone derived from a patient with reactive arthritis, two alloreac-
tive T cell lines, two antigen-specific T cell lines and allogeneic resting T cells were 
analyzed for their responses to monocytes and macrophages derived from monocytes by 
in vitro differentiation.The autoreactive T cell clone strongly proliferated in response to 
fresh monocytes and to macrophages derived from a 7 day culture, but only poorly to 
monocytes cultured for 2 days. In contrast, alloreactive and antigen-specific T cell lines 
proliferated to all stimulator cells equally well. Finally, primary mixed lymphocyte 
reactions could be stimulated by both fresh and 2-day cultured monocytes, but not by in 
vitro derived macrophages. The impaired response of the autoreactive T cell clone to 2-
day cultured monocytes could not be attributed to reduced expression of several well-
defined surface molecules nor to induction of nonresponsiveness. Neither allogeneic 
monocytes nor cytokines (IL-1, IL-2, IL-4, IL-6) could correct the defective response of 
the autoreactive T cell clone. However, preculture of monocytes in the presence of 
interferon-gamma, IL-1, IL-4 or IL-6 retained their stimulatory capacity. Our interpre-
tation of the selectively impaired response of the autoreactive T cell clone is that it most 
likely recognizes a differentiation-dependent monocyte/macrophage-specific peptide. 
* Current address: Klinik fur Innere Medizin I, Franz-Josef-StrauG-Allee 11, 93053 
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Introduction 
T cell activation requires a complex interplay of antigen-specific T cell-
accessory cell interactions via TCR/CD3-MHC/peptide complex and anti-
gen-independent interactions via adhesion molecules, costimulatory ligands 
and cytokines (1). Monocytes and dendritic cells are considered to be 
professional accessory cells capable of stimulating both primary and 
secondary T cell responses (2). On the other hand, the dominant function of 
tissue macrophages is phagocytosis and cytotoxicity, while accessory func-
tions are strongly reduced (3-5). Monocyte differentiation to macrophage-
or dendritic-like phenotypes can be induced by in vitro culture in the 
presence of serum (6-9). Similar to tissue macrophages, in vitro matured 
macrophages show impaired accessory functions in mitogen-induced T cell 
responses (9, 10) and mixed lymphocyte reactions (6). The present study 
was performed to test the ability of in vitro differentiated monocytes to 
stimulate different secondary T cell responses. It turned out that antigen-
specific and alloreactive T cell lines could be equally restimulated by 
different monocyte differentiation stages, while an autoreactive T cell clone 
was selectively unable to recognize monocytes cultures for 2 days. 
Materials and Methods 
Blood donors 
Mononuclear cells (MNC) and T cell lines were derived from donor U A (HLA A2,32; 
B27, 51; DR11.1, 11.3) (11) and donor MS (HLA A l ; B8, w60; DR3, 11.1). Additional 
HLA-taped M N C and EBV-transformed B cell lines were kindly provided by Dr. 
A R L E T T E U R L A C H E R (Blood Bank, Strasbourg, France). 
Establishment of T cell lines 
The origin and specificity of T cell lines used in this study is summarized in Table 1. The 
autorective T cell clone UA-S2 was derived from IL-2-supplemented limiting dilution 
cultures of synovial fluid lymphocytes of patient UA suffering from reactive arthritis 
(11). UA-S2 recognizes a so far unknown peptide in association with HLA-DR 11.3 (11, 
12). The expressed TCR a and P chains of UA-S2 have been sequenced (13). The 
alloreactive T cell clone MS-UA-B12 was derived by stimulation of M N C from donor 
MS with irradiated M N C from donor U A under limiting dilution conditions. It 
recognizes HLA-DR 11.3-typed and some DR 11.4-typed M N C or B cell lines (not 
shown). The alloreactive cell line PLT->UA was produced by a primary stimulation of 
lymphocytes of donor N N (not HLA-typed) with irradiated M N C from donor U A in 
bulk culture and shows a proliferative response to all DR 11 positive M N C or B cell lines 
(not shown). Similarly, cell line PLT->MS was established using stimulator cells from 
donor MS. Antigen-specific T cell clones MS-PPD-B5 and MS-PEP-N1 were derived 
from primary cultures of M N C from donor MS stimulated with PPD (25 Jig/ml, 
Behring, Marburg, Germany) or pork pepsin (1 jig/ml, Sigma, Miinchen, Germany) and 
subsequent limiting dilution cloning and subcloning (14). The phenotype of all T cell 
lines was TcRap +CD3 +CD4 +CD8"CD29 h i g h . 
T cell lines were maintained in medium R P M I 1640 supplemented with penicillin (100 
U/ml), streptomycin (100 ug/ml), glutamine (2 mM), 10% FCS (all reagents from Bio-
chrom, Berlin, Germany), 2.5 % human A B serum and highly purified human natural 
IL-2 (20 U / m l , Biotest, Dreieich, Germany). For primary cultures 10% autologous 
serum was used instead of FCS. Every two weeks, the T cell lines were restimulated with 
irradiated (30 Gy) allogeneic M N C and monoclonal anti-CD3 antibody BMA030 (10 ng/ 
ml, Behring). Mycoplasma contaminations were excluded by periodical assays for 
mycoplasmal adenosine phosphorylase (MycoTect, Gibco, Grand Island, N Y , USA) 
using mouse 3T3 fibroblasts as indicator cells for toxic substrate formation. 
Separation of mononuclear cell fractions 
M N C were isolated from cytapheresis concentrates of donors U A or MS by Ficoll 
density gradient centrifugation. Lymphocyte- and monocyte-enriched fractions were 
prepared by countercurrent centrifugal elutriation in a Beckman J2/21 as described in 
detail by A N D R E E S E N et al. (15) and cryopreserved in small aliquots in liquid nitrogen in 
the presence of 50% FCS and 10% D M S O . The monocyte-enriched fractions from 
donors U A and MS contained 70% and 83% C D 1 4 + cells, respectively. The lympho-
cyte-enriched fractions contained less than 0.3% C D 1 4 + cells. 
Monocyte culture 
Monocyte-enriched cell fractions were carefully thawed at appropriate time points by 
stepwise addition of R P M I 1640 at 4 ° C and washed twice with medium (300 x g, 10 min, 
4 ° C ) . The recovery of vital cells (trypan blue exclusion) was always greater than 80%. 
Cells were resuspended in R P M I 1640 supplemented with antibiotics, glutamine and 2 % 
human A B serum and seeded at different cell concentrations (1 x 103 to 4 x 104) into flat 
bottom microtiter ELISA plates (Greiner, Nurtingen, Germany). After 2 h non-adherent 
cells were removed by washing the plates with medium twice. Cultures were continued 
in R P M I 1640 + 2 % A B serum for 2 or 7 days. Where indicated, recombinant human 
cytokines were added from the start of cultures (interferon-gamma, rhIFN-gamma, 200 
U / m l , Bioferon, Laupheim, Germany; interleukin-1 P, rhIL-1, 1 ng/ml, kindly provided 
by Dr. W. C O N C A , Freiburg; interleukin-4, rhIL-4, 100 U / m l , kindly provided by Dr . S. 
G I L L I S , Immunex, Seattle, W A , U S A ; interleukin-6, rhIL-6, 100 U / m l , Boehringer, 
Mannheim, Germany). 
Proliferative response 
After 2 h, 2 days or 7 days of monocyte culture the medium was replaced by test medium 
(RPMI 1640+10% FCS+ 2.5% human pooled serum). At these time points, viability 
of the cultures was checked microscopically and in some experiments by M T T reduction 
tests (not shown) of parallel cultures. T cell lines were added to the adherent cell layer at 
2x 104 per well. In the case of antigen-specific T cell lines, assays were performed in 
parallel with and without antigens (25 ug/ml P P D or 1 fig/ml pepsin). Some assays were 
supplemented with cytokines (concentrations indicated above), anti-CD3 antibody 
(BMA030, 10 ng/ml), anti-CD 28 antibody (9.3, 1:8000, kindly provided by Dr. J . A . 
L E D B E T T E R , Seattle, W A , USA) , or allogeneic monocyte enriched cell fraction (2x 104/ 
well). In some experiments, anti-CD3 antibody or fresh autologous monocytes were 
added 24 h later. The cultures were pulsed (18 h) with 3H-thymidine after 48 h. For M L C 
cultures allogeneic lymphocytes, depleted from monocytes by counterflow centrifuga-
tion, were added at 1 x 105 per well and pulsed with 3H-thymidine after 5 days. 
Proliferative responses are given in counts per min (cpm) and represent the mean of 
triplicates; standard deviations were sometimes elevated due to inhomogenous distribu-
tion of monocytes in the wells but always below 25%. Background 3H-thymidine 
uptake of monocytes was usually below 200 cpm and was subtracted. 
Surface antigen expression 
T cell lines were phenotyped by flow cytometry (FACStar Plus, Becton-Dickinson) 
using phycoerythrin- or fluorescein-conjugated monoclonal antibodies: anti-TcRap 
(BMA031, Behring), anti-CD3 ( U C H T l ) and anti-CD8 (DK25, Dako), anti-CD4 
(IOT4, Dianova-Immunotech), anti-CD29 (4B4, Coulter). Monocyte surface antigen 
expression was evaluated either by cell ELISA or by flow cytometry. The cell ELISA 
system has been described previously (15). Briefly, monocytes were cultured in microli-
ter plates as described above, fixed at 4°C with 0.05% glutaraldehyde for 10 min and 
treated with monoclonal antibodies against p2-microglublin (P2M, Becton Dickinson), 
C D 14 (My4, Coulter), H L A - D R / D P (Tu39, Biotest) and the differentiation-dependent 
antigen gp68-MAX.3 (16). Specifically bound antibodies were detected by peroxidase-
conjugated second antibody, developed with phenyl-diaminedichloride and optical 
density was read at 486 nm. Results are given as percentage of P2M expression (antigen 
expression index). For flow cytometric analysis, monocytes were cultured in teflon bags 
(7). Cells were stained by direct (CD14, My4, Coulter; H L A - D R , Becton-Dickinson; 
I C A M - 1 , CD54, Dianova-Immunotech; all antibodies fluorescein-conjugated) or indi-
rect immunofluorescence (LFA-3 , TS2.9, kindly provided by Dr. S. C . M E U E R , Heidel-
berg; second antibody: fluorescein-conjugated goat-F(ab)2-anti-mouse-IgG, Dianova, 
Hamburg, Germany). Staining was performed in the presence of 1 % human IgG to 
reduce unspecific binding. Isotype matched mouse IgG (Becton-Dickinson) was used for 
control staining. 
Results 
We used a monocyte culture system in microtiter plates to investigate the 
effect of differentiation on auto-, alio- and soluble antigen induced T cell 
proliferation. Monocyte differentiation into mature macrophages was mon-
itored microscopically and by expression of the macrophage marker 
MAX.3 (Tab. 2). Analysis of monocyte surface markers known to be 
involved in T cell activation (HLA-DR, CD14, ICAM-1, LFA-3) did not 
reveal any major changes of expression during monocyte cultures (Tab. 2). 
Various T cell lines with different specificities (Tab. 1) and resting 
monocyte-depleted T cells were cocultured with monocytes or accessory 
Table 1. Characterization of T cell lines. 
U A - S 2 a MS-UA-B12 P L T - > U A MS-PPD-B5 M S - P E P - N l b 
Donor U A MS N N MS MS 
Primary 
stimulation IL-2 U A U A P P D pepsin 
Specificity autoreactive alloreactive autoreactive P P D pepsin 
Restriction D R 11.3 D R 11.3 D R 11 D R 3 D R 3 
A SCHLESIER et al. (11); b L A C O U R et al. (14, 34) 
Table 2. Phenotypical characterization of cultured monocytes. 
Monocyte Phenotype 
culture 
Cell E L I S A a Flow cytometry1* 
P2M CD14 M A X . 3 H L A - D R Control CD14 H L A - D R I C A M - 1 L F A - 3 
Day 0 1.8 85 12 96 190 600 (90) 510 (93) 390 (97) 455 (99) 
Day 2 1.8 86 27 85 210 610 (82) 590 (87) 620 (87) 520 (87) 
Day 7 2.2 112 58 110 300 670 (96) 590 (77) 690 (90) 610 (95) 
a Antigen expression index calculated on the basis of p2-microgobulin (P2M) expression ( O D 4 8 6 ) (15). 
b Mean channel fluorescence (% positive cells) measured with a FACStar Plus (Becton-Dickinson). The table shows representative data from 1 out 
of 2 experiments that are in accordance with previously published results (15). 
cells derived from monocytes by culture for 2 or 7 days. Experiments with 
monocytes derived from 2 donors (Fig. 1) revealed that the alloreactive T 
cell clone MS-UA-B12 and 2 alloreactive T cell lines (PLT - > U A and PLT 
- > MS) were stimulated equally by all monocyte differentiation stages 
(Fig. 1 A). The same was true for the antigen-specific T cell clones MS-PPD-
B5 and MS-PEP-N1 (Fig. IB). On the contrary, primary alloreactive T cell 
responses (MLC) could be equally stimulated by fresh and 2-day cultured 
monocytes but not by macrophages derived from 7-day cultures (Fig. 1C). 
In clear contrast to the alloreactive and antigen-specific responses, the 
autoreactive T cell clone UA-S2 of synovial fluid origin did not respond to 
2-day cultured monocytes in several independent experiments, although 
strongly proliferating in response to fresh monocytes and in vitro derived 
macrophages (Fig. ID). The impaired stimulatory capacity of monocytes 
A secondary alloreactive response B secondary soluble antigen 
response 
c o 
§• C primary alloreactive response D autoreactive response 
0 40 0 40 0 40 x 10 3 0 40 0 40 0 40 x 10~3 
0 2 7 0 2 7 
Monocyte culture (days) 
Figure 1. Response of alloreactive, antigen-specific and autoreactive T cells to different 
maturation stages of monocytes. Appropriate elutriation-enriched monocytes of donor 
U A or MS were seeded in microtiter plates at 2.5 x 103, 1 x 104 and 4 x 104 cells/well. (A, 
B , D ) Various T cell lines (2x l0 4 ) or (C) monocyte depleted lymphocytes ( M L C , 
1 x 105) were added either immediately (day 0) or after 2 days or 7 days of monocyte 
preculture. Antigens (pepsin or PPD) were included in assays with antigen-specific T cell 
clones ( B ) ; proliferative responses in the absence of antigens were always below 200 cpm. 
Proliferative responses were quantified by a 18 h pulse of 3H-thymidine after 48 h in the 
case of secondary responses or after 5 days in the case of M L C . Individual experiments 
are shown for all cell types. 
Table 3. Impaired stimulation of UA-S2 by 2 day cultured monocytes is not due to 
suppression. 
Stimulus Proliferative 
response (cpm) 
Medium 10 
Ant i -CD3 10 
Fresh monocytes 5910 
Fresh monocytes + anti-CD3 16560 
2d monocytes 140 
2d monocytes + anti-CD3 10440 
2d monocytes + fresh monocytes 7710 
7 d monocytes 6210 
7d monocytes + anti-CD3 9360 
7d monocytes + fresh monocytes 5600 
U A monocytes were seeded at 4 x 104 per well and precultured for 2 or 7 days in R P M I 
1640 medium supplemented with 2 % A B serum. Fresh U A monocytes were added at 
4 x 104 per well and anti-CD3 antibody (BMA030) at 10 ng/ml. UA-S2 (2 x l O 4 per well) 
was cocultured for 48 h and then pulsed with 3H-thymidine for additional 18 h. 
already became obvious after a one day culture and lasted for 4 days (not 
shown) and was observed with a wide range of monocyte concentrations 
tested (up to 1 x 105 cells/well). In contrast, primary and secondary 
alloreactive responses tested in parallel during the same experiment were 
never decreased at day 2 of monocyte culture, thus excluding experimental 
variations in monocyte cultures as the cause of impairement. Addition of 
anti-CD3 antibody or fresh autologous monocytes completely restored the 
response of UA-S2 to 2-day cultured monocytes (Tab. 3) excluding sup-
pressive effects of the «medium-aged» macrophages. More importantly, 
even the delayed addition of anti-CD3 or fresh monocytes restored the 
proliferative response of UA-S2 also excluding induction of nonresponsive-
ness as the underlying mechanism (Tab. 4). In contrast, the impaired 
response to 2-day cultured monocytes could neither be restored by addition 
of cytokines (IL-1, IL-4, IL-6) or anti-CD28 antibody, nor by addition of 
allogeneic monocytes. However, monocytes precultured during 2 days in 
the presence of IFN-gamma were still able to induce UA-S2 proliferation 
(3310 cpm vs. 740 cpm with IFN-gamma vs. medium cultured monocytes). 
A similar but less pronounced effect was observed after monocyte precul-
tures in the presence of IL-1, IL-6, and IL-4 (not shown). 
Discussion 
In this study we evaluated the effect of in vitro maturation on accessory 
function of monocytes/macrophages. In contrast to monocytes, in vitro 
differentiated macrophages were only weak stimulators of primary alloreac-
Table 4. Impaired stimulation of UA-S2 by 2-day cultured monocytes is not due to 
induction of nonresponsiveness and cannot be restored by cytokines or allogeneic 
monocytes. 
Presence of 
2-day cultured 
U A monocytes 
Supplementation Proliferative response 
UA-S2 B12 
_ Medium 12 11 
- IL-2 (20 U/ml) 22 180 
- Fresh U A monocytes 4680 3910 
+ Medium 740 4510 
+ anti-CD3 (10 ng/ml) after 24 h 6690 6150 
+ fresh U A monocytes after 24 h 3510 7610 
+ IL-2 (20 U/ml) 2170 5110 
+ rhIL-4 (100 U/ml) 880 5680 
+ rhIL-1 (1 ng/ml) 1320 6320 
+ rhIL-6 (100 U/ml) 1170 5950 
+ anti-CD28 (9.3; 1:8000) 960 4020 
+ allogeneic monocytes 860 7090 
U A monocytes were seeded at 4 x 104 per well and precultured for 2 days in R P M I 1640 
medium supplemented with 2 % A B serum. A t the day of assay the medium was replaced 
by R P M I 1640 medium with 10 % FCS and 2 % A B serum; UA-S2 or MS-UA-B12 were 
added at 2 x 104 per well. Cytokines, monoclonal antibodies, allogeneic monocytes from 
donor MS (2 x 104 per well) or fresh U A monocytes (2 x 104 per well) were added either 
simultaneously or after 24 h. 48 h after onset the assay was pulsed with 3H-thymidine for 
additional 18 h. The data represent a typical experiment out of 3 similar experiments. 
tive T cell responses which is consistent with other reports (5, 10). Simi-
larly, primary T cell responses cannot be induced by fixed A P C (17), B cell 
lines (18) or interferon-gamma-treated endothelial cells, fibroblasts or 
chondrocytes (19, 20), a failure supposed to be due to insufficient or altered 
production of necessary costimulatory signals, cytokines or processed 
antigen peptides (21). 
On the other hand, it is widely accepted that induction of secondary T 
cell responses is not strictly dependent on professional A P C . Human T cell 
lines have been shown to respond to alloantigens and soluble antigens 
presented by B cell lines (22) or IFN-gamma-treated fibroblasts, endothelial 
cells (19) or chondrocytes (20). In this study we extend this listing by 
demonstrating that in vitro derived macrophages, in contrast to their 
inability to stimulate primary responses, are clearly capable of stimulating 
secondary alloreactive and antigen-specific responses as efficiently as 
monocytes. Similarly, in the murine system, antigen-specific T cell lines 
could be restimulated by antigens presented on peritoneal macrophages (23, 
24). On the basis of the above-mentioned facts the response pattern of the 
autoreactive T cell clone UA-S2 is most striking. The inability of mono-
cytes cultured for 2 days to stimulate UA-S2 cannot be attributed to a 
deficient costimulatory signal because of the following reasons: i) various 
secondary and even primary T cell responses were stimulated equally well 
by cultured monocytes, ii) molecules necessary in T cell-monocyte interac-
tions like H L A - D R , CD14, LFA-3, and ICAM-1 were not deficient on 
cultured monocytes, iii) allogeneic monocytes, cytokines (25, 26), and anti-
CD28 antibody (27) could not restore the impaired response, and most 
importantly, iv) nonresponsiveness that is induced by A P C in the absence 
of adequate costimulation (27) was not observed with UA-S2, since the 
clone was fully responsive to fresh monocytes or anti-CD3 antibody after 
preincubation with cultured monocytes for 24 h. Therefore we propose that 
the only plausible explanation for the failure of cultured monocytes to 
stimulate UA-S2 is the lacking presentation of the peptide recognized by 
the T cell receptor of UA-S2. This peptide may be either derived from a 
differentiation-dependent monocyte-specific protein or produced by a 
differentiation-dependent protease. This suggestion is in agreement with 
the observed major changes in phenotype and enzyme content after 2 days 
of culture during in vitro differentiation of monocytes to macrophages (8, 
15, 28). It also explains the failure of an autologous B cell line to stimulate 
UA-S2 (11). Although cell type-restricted autoreactive T cells have been 
described, the nature of the peptides recognized has not been uncovered 
(29). This is, to our knowledge, the first report on a differentiation-
dependent autoreactive response. Culture-dependent loss of antigen-pre-
senting ability for exogenous soluble antigens has been described for 
murine macrophages and explained by the inability of cultured A P C to 
produce the correct peptides due to changes in the proteolytic system (24). 
The cytokines IFN-gamma, IL-1, IL-6, and IL-4 to some extent retained 
the stimulatory potential of cultured monocytes in the UA-S2 system. This 
may be due to the documented effects of these cytokines on differentiation 
and accessory function. Especially IFN-gamma is a strong enhancer of 
accessory activity due to upregulation of several surface molecules like 
M H C class II antigens, ICAM-1 and B7/BB1 (19, 30-32). IL-1, IL-6, and 
IL-4 have been shown to augment the accessory potency of cultured 
monocytes in mitogen-driven T cell responses (28, 33). Thus, culture of 
monocytes in the presence of these cytokines may induce and/or maintain 
the presentation of the antigenic peptide to UA-S2. 
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